TrialDiabetes, obesity & metabolism2021

Pharmacokinetic and pharmacodynamic bioequivalence of biosimilar MYL-1601D with US and European insulin aspart in healthy volunteers: A randomized, double-blind, crossover, euglycaemic glucose clamp study.

Ulrike Hövelmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.